Design-Stage Trial of Gentamicin in the Uniject Device

Overall knowledge levels were high. No difference was observed regarding FCHV age andknowledge (Table 9). There was no association between literacy status and knowledge of gentamicinin Uniject in either group of FCHVs (those who treated PSBI and those who did not treat PSBI)(Tables 9 and 10). Similarly, knowledge levels increased slightly from post-training to postimplementation.Figure 20. An FCHV with hertreatment register.Figure 21. FCHV giving gentamicin in Uniject.Table 9. Knowledge of the Uniject device among FCHVs who treated PSBI, accordingto literacy status, time point, and treatment experience (n=33).Knowledge on Uniject deviceLiterate Semi-literate Illiterate(n=22)(n=9) (n=2)TotalPT PI PT PI PT PI PT PIOverall knowledge of Uniject deviceperformance17 17 4 7 1 2 20 24Correct timing of cap removal 22 21 8 9 1 1 29 29Knowledge on activation of Uniject device 20 20 8 9 2 2 28 30Knowledge on correct method of injection 22 22 9 9 2 2 31 30Knowledge of correct angle of injection 22 22 9 7 2 2 31 28Knowledge of correct disposal of usedgentamicin in Uniject syringes19 22 9 9 2 2 28 31Knowledge of correct disposal of disposalboxes22 22 9 8 2 2 31 30Sources: post-training (PT) and post-implementation (PI) questionnaires.Final Report(28) Gentamicin in Uniject: A Feasibility Study